Author:
Barcellos Heloísa Helena de Alcantara,Kalichak Fabiana,da Rosa João Gabriel Santos,Oliveira Thiago Acosta,Koakoski Gessi,Idalencio Renan,de Abreu Murilo Sander,Giacomini Ana Cristina Varrone,Fagundes Michele,Variani Cristiane,Rossini Mainara,Piato Angelo L,Barcellos Leonardo José Gil
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. INCB. International Narcotics Control Broad. Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purpose: Analysis of world situation. Cap.3, 49–67 (2015).
2. Lieberman, J. A. et al. Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine. 353, 1209–1223 (2005).
3. Grady, M. A., Gasperoni, T. L. & Kirkpatrick, P. Aripiprazole. Nature reviews/drug discovery. 2, 427–428 (2003).
4. Marder, S. R. et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophrenia Research. 61, 123–136 (2003).
5. Keck, P. E. et al. Aripiprazole Study Group. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. American Journal of Psychiatry. 160, 1651–1658 (2003).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献